Pharmaceutisch Weekblad

, Volume 12, Issue 3, pp 97–103 | Cite as

Utilization patterns of non-steroidal anti-inflammatory drugs in an open Dutch population

  • Hubert G. Leufkens
  • Caroline B. Ameling
  • Yechiel A. Hekster
  • A. Bakker
Research Reports


Non-steroidal anti-inflammatory drugs represent an important drug class in ambulatory care. A utilization study among half a million persons showed that 8.6% could be identified as having used one or more non-steroidal anti-inflammatory drugs (excluding salicylates) in 1987. Data were drawn from a representative sample of pharmacy records which comprise full medication histories of individual patients. Overall utilization of non-steroidal antiinflammatory drugs was 10.8 defined daily doses/(1000 persons · day). Approximately three quarters of the patients are ‘incidental’ users and receive non-steroidal anti-inflammatory drugs for a relatively short time (30 days or less). Patients who were identified as ‘regular’ (31–210 days of therapy) and ‘heavy’ (>210 days of therapy) users, accounted for 21.2% respectively 4.8% of all users. ‘Heavy’ users are responsible for 17.3% of all non-steroidal anti-inflammatory drug prescriptions. Especially the elderly and females are prone to be ‘heavy’ users. Five drugs account for 90.4% of all prescriptions (diclofenac, ibuprofen, naproxen, piroxicam, indometacin). A total of 71.1% of the patients with more than one prescription for non-steroidal anti-inflammatory drugs switched in therapy. There are two classes of concomitant drug use especially relevant with respect to detecting non-steroidal anti-inflammatory drugs-associated risks: H2 blockers and antacids (belonging to anatomical therapeutic and chemical anatomic class A) and diuretics (belonging to anatomical therapeutical chemcial anatomic class C). More than half of the ‘heavy’ users showed concomitant use of drugs in these classes.


Anti-inflammatory agents Data collection Drug utilization Epidemiologic methods Netherlands Pharmacies, community 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baum C, Kennedy DL, Forbes MB. Utilization of non-steroidal anti-inflammatory drugs. Arthr Rheum 1985;28:686–92.Google Scholar
  2. 2.
    Steele K, Mills KA, Gilliland AEW, Irwin WG, Taggart A. Repeat prescribing of non-steroidal antiinflammatory drugs excluding aspirin: how careful are we? Br Med J 1987;295:962–4.Google Scholar
  3. 3.
    Bergman U, Dahlstrom M, Sanz EJ. Use of non-steroidal anti-inflammatory drugs and other minor analgesics in Sweden. Proceedings of the workshop ‘Pharmacotherapy in osteoarthritis’. Uppsala: Drug Information Committee, National Board of Health and Welfare, 1989:2.Google Scholar
  4. 4.
    Urquhart J. Two cheers for NSAIDs. Gut 1986;27:1287–91.PubMedGoogle Scholar
  5. 5.
    Weber JPC. Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. Adv Inflam Res 1984;6:1–15.Google Scholar
  6. 6.
    Committee on Safety of Medicines. Non-steroidal antiinflammatory drugs and serious gastro-intestinal adverse reactions. Br Med J 1986;292:614–6.Google Scholar
  7. 7.
    Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of NSAID in Saskatchewan, Canada 1983. J Clin Epidemiol 1988;41:35–45.CrossRefPubMedGoogle Scholar
  8. 8.
    Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of non-steroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987;147:85–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Blackshear JL, Napier JS. Renal complications of nonsteroidal anti-inflammatory drugs: identification and monitoring of those risk. Semin Arthr Rheum 1985;14:163–75.CrossRefGoogle Scholar
  10. 10.
    Van den Ouweland FA, Gribnau FWJ, Meyboom RHB. Congestive heart failure due to anti-inflammatory drugs in the elderly. Age Ageing 1988;17:8–16.PubMedGoogle Scholar
  11. 11.
    De Smet PAGM. The Dutch approach to computerized drug information. J Soc Adm Pharm 1988;5:49–58.Google Scholar
  12. 12.
    Isacson D, Smedby B. Defining heavy use of prescription drugs. Med Care 1988.Google Scholar
  13. 13.
    Rothman KJ. Modern epidemiology. Boston: Little, Brown and Company, 1986.Google Scholar
  14. 14.
    SAS/STAT Guide for personal computers. Cary: SAS Institute, 1985.Google Scholar
  15. 15.
    Arnold M, Schrieber L, Brooks P. Immunosuppresive drugs and corticosteroids in the treatment of rheumatoid arthritis. Drugs 1988;36:340–63.PubMedGoogle Scholar
  16. 16.
    Nordic Council on Medicines. Nordic statistics on medicines 1984–1986. Uppsala: Nordic Council on Medicines, 1988.Google Scholar
  17. 17.
    Hekster YA, Stuart CJAM, Leufkens HGM, et al. Epidemiologie van het gebruik van analgetica [Epidemiology of the use of analgesics]. J Drug Ther Res 1988;13:44–8.Google Scholar
  18. 18.
    Anoniem. Svensk låkemedelsstatistik 1988 [Swedish statistics on medicines]. Stockholm: Apoteksbolaget, 1989.Google Scholar
  19. 19.
    Jick SS, Walker AM, Perera DR, Jick H. Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet 1987;2:38–2.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1990

Authors and Affiliations

  • Hubert G. Leufkens
    • 1
  • Caroline B. Ameling
    • 1
  • Yechiel A. Hekster
    • 2
  • A. Bakker
    • 1
  1. 1.Department of PharmacoepidemiologyUtrecht UniversityAD UtrechtThe Netherlands
  2. 2.Department of Clinical PharmacyUniversity Hospital NijmegenHB NijmegenThe Netherlands

Personalised recommendations